Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-01-11 @ 2:11 AM
Study NCT ID:
NCT01604850
Status:
COMPLETED
Last Update Posted:
2014-05-28
First Post:
2012-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-21
First Submit QC Date:
None
Study First Post Date:
2012-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-31
Results First Submit QC Date:
None
Results First Post Date:
2014-05-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-09
Last Update Post Date:
2014-05-28
Last Update Post Date Type:
ESTIMATED